Also trades as: 0R2M.L (LSE) · $vol 1M

$638.88

-3.71 (-0.58%)

Weekly Expected Move ±4.6%

$634 $666 $698 $730 $763

NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 36 · $65.8B mcap · 101M float · 0.747% daily turnover · Short 24% of daily vol

Revenue

$14.3B +1.0% ▲

5Y CAGR: +11.0%

Gross Profit

$12.2B +0.1% ▲

5Y CAGR: +11.4%

Operating Income

$3.6B -10.3% ▼

5Y CAGR: +0.0%

Net Income

$4.5B +2.1% ▲

5Y CAGR: +5.1%

EPS (Diluted)

$41.48 +8.2% ▲

5Y CAGR: +6.3%

EBITDA

$5.8B +9.4% ▲

5Y CAGR: +7.2%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$16.1B	$12.2B	$13.1B	$14.2B	$14.3B
YoY Growth	+89.1%	-24.3%	+7.8%	+8.3%	+1.0%
Cost of Revenue	$2.7B	$1.7B	$2.2B	$2.0B	$2.1B
Gross Profit	$13.3B	$10.5B	$10.9B	$12.2B	$12.2B
Gross Margin	83.1%	86.0%	82.9%	86.1%	85.4%
R&D Expenses	$2.6B	$3.1B	$4.0B	$5.2B	$5.9B
SG&A Expenses	$1.8B	$2.1B	$2.5B	$3.0B	$2.7B
Operating Expenses	$4.4B	$5.1B	$6.5B	$8.2B	$8.7B
Operating Income	$8.9B	$5.4B	$4.3B	$4.0B	$3.6B
Operating Margin	55.7%	44.2%	33.2%	28.1%	24.9%
Interest Expense	$57M	$59M	$73M	$55M	$44M
Income Before Tax	$9.3B	$4.9B	$4.2B	$4.8B	$5.2B
Tax Expense	$1.3B	$520M	$246M	$367M	$726M
Net Income	$8.1B	$4.3B	$4.0B	$4.4B	$4.5B
Net Margin	50.2%	35.6%	30.1%	31.1%	31.4%
EPS (Diluted)	$71.97	$38.22	$34.77	$38.34	$41.48
EBITDA	$9.7B	$5.3B	$4.7B	$5.3B	$5.8B
Shares Outstanding	112M	114M	114M	115M	109M

Line Item	FY2024 Q2	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1
Revenue	$3.5B	$3.7B	$3.8B	$3.0B	$3.7B	$3.8B	$3.9B	$3.6B
Cost of Revenue	$480M	$491M	$565M	$464M	$530M	$522M	$585M	$669M
Gross Profit	$3.1B	$3.2B	$3.2B	$2.6B	$3.1B	$3.2B	$3.3B	$2.9B
Gross Margin	86.5%	86.8%	85.1%	84.7%	85.6%	86.1%	84.9%	81.4%
R&D Expenses	$1.2B	$1.3B	$1.4B	$1.3B	$1.4B	$1.6B	$1.6B	$1.6B
SG&A Expenses	$759M	$714M	$792M	$633M	$634M	$658M	$775M	$648M
Operating Expenses	$2.0B	$2.1B	$2.2B	$2.0B	$2.1B	$2.2B	$2.4B	$2.3B
Operating Income	$1.1B	$1.2B	$990M	$592M	$1.1B	$1.0B	$880M	$643M
Operating Margin	30.2%	31.7%	26.1%	19.5%	29.4%	27.3%	22.7%	17.8%
Interest Expense	$15M	$14M	$10M	$9M	$4M	$19M	$12M	$13M
Income Before Tax	$1.6B	$1.5B	$958M	$905M	$1.5B	$1.8B	$1.0B	$831M
Tax Expense	$196M	$152M	$40M	$96M	$127M	$303M	$199M	$104M
Net Income	$1.4B	$1.3B	$918M	$809M	$1.4B	$1.5B	$845M	$727M
Net Margin	40.4%	36.0%	24.2%	26.7%	37.9%	38.9%	21.7%	20.2%
EPS (Diluted)	$12.41	$11.54	$8.06	$7.27	$12.81	$13.62	$7.86	$6.75
EBITDA	$1.8B	$1.6B	$1.1B	$1.0B	$1.7B	$1.9B	$1.2B	$967M
Shares Outstanding	115M	116M	114M	111M	109M	107M	108M	108M

REGN NASDAQ